Graminex Receives Foreign Site Reference Number

The FSRN Notice of Acceptance authorizes Graminex to manufacture, package, and label natural health products for distribution to Canada.

Image courtesy of Graminex.

Deshler, OH—Graminex has received its Foreign Site Reference Number from Health Canada, according to a press release.

The company’s site in Deshler, Ohio was found to be in compliance with Good Manufacturing Practices according to Health Canada. The FSRN Notice of Acceptance authorizes Graminex to manufacture, package, and label natural health products for distribution to Canada. This includes G63® Flower Pollen Extract, which has an approved Master File registration with Health Canada.

“This is a big step for Graminex as we continue to build out our infrastructure and capabilities here in Deshler,” said Heather J. May, CEO, in the press release. “We have 6 world-class encapsulators and tablet presses where we specialize in more technically-challenging projects, particularly with oils and difficult to run botanicals in both large and small batch sizes.”

Related: Product Profiles: Nutrasource IGEN Testing Program
Nutri-Beauty Ingredient Granted NPN by Health Canada
NattoPharma Secures Patents in Canada and South Korea

Foreign Site Reference Number: 5000594 was issued by the Natural and Non-prescription Health Products Directorate (NNHPD) to Graminex®, L.L.C. on August 25, 2021.